Core 5-Panel
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
An amphetamines urine test is a qualitative screening that detects the presence of amphetamine, methamphetamine, MDMA (ecstasy), and related compounds or their metabolites in urine. This test covers a broad class of central nervous system stimulants.
This test detects the presence of amphetamine-type substances and their metabolites in urine. The amphetamine class includes amphetamine, methamphetamine, and MDMA, among others. The test provides a qualitative result indicating whether these substances are present above the assay cut-off level.
Immunoassay screening may show cross-reactivity with structurally similar compounds. Confirmatory testing can differentiate between specific amphetamine-type substances.
Amphetamine detection is a standard component of workplace drug screening, clinical toxicology assessment, and substance use treatment monitoring. These substances affect the cardiovascular and central nervous systems.
It is important to note that certain prescribed medications, such as those for ADHD, may produce a positive result. Clinical context and confirmatory testing are essential for accurate interpretation.
Testing may be relevant as part of standard workplace drug screening, pre-employment testing, clinical evaluations, substance abuse treatment monitoring, or when amphetamine use is suspected.
Consult a healthcare professional for guidance on testing protocols and result interpretation, particularly when prescribed stimulant medications are involved.
This marker is included in the following test panels.
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
Individual amphetamine screening with laboratory confirmation.